The Fianna Fáil Spokesperson on Dublin Senator Darragh O’Brien has welcomed news of a breakthrough in the availability of a life-changing drug for Multiple Sclerosis.
In response to queries from Senator O’Brien, the HSE has confirmed that it is in the final stages of putting in place arrangements to fund the availability of the drug Fampyra in Ireland.
It follows a long campaign from MS sufferers who say their standard of living could be dramatically improved if they had access to the drug, led by Balbriggan man Gerry Murphy.
North Dublin Senator Darragh O’Brien has lobbied the Minister for Health on the issue for over a year, raising it in the Seanad on several occassions. He said this news will come as welcome relief to MS sufferers.
“Fampyra is proven to work for around a third of MS sufferers. This means that the lives of around 3,000 people with Multiple Sclerosis in Ireland could be drastically improved by the availability of the drug here,” said Senator O’Brien
“This is a mobility drug that helps people with later stage MS to walk and retain control over their bodies, thereby allowing them to stay in work and live independently. The drug is currently not available under the drug payment scheme, putting it out of the reach of thousands of MS sufferers in Ireland. As a result, many are confined to a wheelchair and have been forced to give up work.
“It is fantastic news that after a vigorous campaign, it looks like MS sufferers will soon have access to this life-changing drug. The HSE has told me that the arrangements should be made ‘in the very near future’.”